Biofrontera Analyst Ratings
Biofrontera Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/31/2023 | 102.93% | Benchmark | → $18 | Reiterates | Buy → Buy |
| 07/05/2023 | 102.93% | Benchmark | $140 → $18 | Maintains | Buy |
| 05/15/2023 | -21.08% | Benchmark | → $7 | Reiterates | Buy → Buy |
| 03/09/2023 | -21.08% | Benchmark | → $7 | Reiterates | → Buy |
| 01/31/2023 | -21.08% | Benchmark | $11 → $7 | Reiterates | → Buy |
| 12/15/2021 | 24.01% | Benchmark | → $11 | Initiates Coverage On | → Buy |
| 11/24/2021 | 125.48% | Roth Capital | → $20 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/31/2023 | 102.93% | 基准 | → 18 美元 | 重申 | 购买 → 购买 |
| 07/05/2023 | 102.93% | 基准 | 140 美元 → 18 美元 | 维持 | 购买 |
| 05/15/2023 | -21.08% | 基准 | → 7 美元 | 重申 | 购买 → 购买 |
| 03/09/2023 | -21.08% | 基准 | → 7 美元 | 重申 | → 购买 |
| 01/31/2023 | -21.08% | 基准 | 11 美元 → 7 美元 | 重申 | → 购买 |
| 2021 年 12 月 15 日 | 24.01% | 基准 | → 11 美元 | 启动覆盖范围开启 | → 购买 |
| 11/24/2021 | 125.48% | 罗斯资本 | → 20 美元 | 启动覆盖范围开启 | → 购买 |
What is the target price for Biofrontera (BFRI)?
Biofrontera（BFRI）的目标价格是多少？
The latest price target for Biofrontera (NASDAQ: BFRI) was reported by Benchmark on August 31, 2023. The analyst firm set a price target for $18.00 expecting BFRI to rise to within 12 months (a possible 102.93% upside). 5 analyst firms have reported ratings in the last year.
Benchmark 于 2023 年 8 月 31 日公布了 Biofrontera（纳斯达克股票代码：BFRI）的最新目标股价。该分析公司将目标股价定为18.00美元，预计BFRI将在12个月内上涨至18.00美元（可能上涨102.93％）。去年有5家分析公司公布了评级。
What is the most recent analyst rating for Biofrontera (BFRI)?
Biofrontera（BFRI）的最新分析师评级是多少？
The latest analyst rating for Biofrontera (NASDAQ: BFRI) was provided by Benchmark, and Biofrontera reiterated their buy rating.
Biofrontera（纳斯达克股票代码：BFRI）的最新分析师评级由Benchmark提供，Biofrontera重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for Biofrontera (BFRI)?
Biofrontera（BFRI）的下一个分析师评级何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biofrontera, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biofrontera was filed on August 31, 2023 so you should expect the next rating to be made available sometime around August 31, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Biofrontera的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。Biofrontera的最后一次评级是在2023年8月31日提交的，因此您应该预计下一个评级将在2024年8月31日左右公布。
Is the Analyst Rating Biofrontera (BFRI) correct?
分析师评级Biofrontera（BFRI）是否正确？
While ratings are subjective and will change, the latest Biofrontera (BFRI) rating was a reiterated with a price target of $0.00 to $18.00. The current price Biofrontera (BFRI) is trading at is $8.87, which is within the analyst's predicted range.
尽管评级是主观的，并将发生变化，但最新的Biofrontera（BFRI）评级得到了重申，目标股价为0.00美元至18.00美元。Biofrontera（BFRI）目前的交易价格为8.87美元，在分析师的预测区间内。